Artificial intelligence is revolutionizing stroke management by improving diagnosis, accelerating treatment, enabling remote ...

Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...

The ASRA releases its fifth iteration of evidence-based guidelines on regional anesthesia in patients on antithrombotic or ...

Chinese clinical scientist Wang Yongjun has been granted the William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International ...

MISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has ...

Thurner syndrome (MTS) is a clinicopathological condition where the left common iliac vein is compressed by the overlying right common iliac artery, potentially leading to deep vein thrombosis (DVT) ...

"He’s had a stroke, but look at him. He’s walking and he’s waving with that weak arm, and he’s trying to communicate," Danielle McGrady said of her grandson Roczen.

LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...

However, the controlled setting inherent to trials may not accurately reflect the complexities of real‐world clinical practice. BEST‐MSU demonstrated that mobile stroke units (MSUs) accelerate ...